Terray Therapeutics
PrivateLast Round
Series B
Oct 17, 2024
Est. Valuation
$600M
Total Funding Raised
$220M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Terray Therapeutics is a biotechnology company that delivers precise chemical datasets to enhance drug discovery through the integration of artificial intelligence, synthetic chemistry, automation, and nanotechnology.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Terray Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Terray Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 17, 2024 | ||||
| Series A | Feb 15, 2022 | ||||
| Seed | Jun 30, 2021 |
Key People
Founding team and executive leadership
Terray Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Maverick Capital | Series B |
| Digitalis Ventures | Seed, Series A, Series B |
| Maverick Capital | Series B |
| Greentrail Partners | Series A |
| XTX Markets | Series A |
| Two Sigma Ventures | Series B, Series A, Seed |
| Alexandria Venture Investments | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 41% MoM, reaching 33.2K.
- Nov 17, 2025
Launched an experiment-driven ML platform for small-molecule discovery.
Terray Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Terray Therapeutics's valuation, stock price, and market status.